Axsome Therapeutics, Inc. (AXSM) › Shares OutstandingAxsome Therapeutics, Inc. (AXSM) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 19.15M2016: 19.15M2017: 25.49M2018: 30.09M2019: 36.93M2020: 37.37M2021: 37.82M2022: 43.50M2023: 47.35M2024: 48.67M2025: 50.88M50.88M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202550.88M+4.6%202448.67M+2.8%202347.35M+8.9%202243.50M+15.0%202137.82M+1.2%202037.37M+1.2%201936.93M+22.8%201830.09M+18.0%201725.49M+33.1%201619.15M+0.0%201519.15M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share